Resilience level and its association with maladaptive coping behaviours in the COVID-19 pandemic: a global survey of the general populations
Por:
Wong M.C.S., Huang, Junjie, Wang H.H.X., Yuan, Jinqiu, Xu, Wanghong, Zheng, Zhi-Jie, Xue, Hao, Zhang, Lin, Jiang, Johnny Y. Y., Huang J.L.W., Chen, Ping, Jia, Zhihui, Palaganas, Erlinda, Viwattanakulvanid, Pramon, Somrongthong, Ratana, Caicedo, Andres, Medina-Arellano, Maria de Jesus, Murphy, Jill, Paredes M.B.A., Withers, Mellissa
Publicada:
1 ene 2023
Resumen:
Background: The coronavirus disease 2019 (COVID-19) pandemic has induced a significant global concern on mental health. However few studies have measured the ability of individuals to “withstand setbacks, adapt positively, and bounce back from adversity” on a global scale. We aimed to examine the level of resilience, its determinants, and its association with maladaptive coping behaviours during the pandemic. Methods: The Association of Pacific Rim Universities (APRU) conducted a global survey involving 26 countries by online, self-administered questionnaire (October 2020-December 2021). It was piloted-tested and validated by an expert panel of epidemiologists and primary care professionals. We collected data on socio-demographics, socioeconomic status, clinical information, lifestyle habits, and resilience levels measured by the Brief Resilience Scale (BRS) among adults aged = 18 years. We examined factors associated with low resilience level, and evaluated whether low resilience was correlated with engagement of maladaptive coping behaviours. Results: From 1,762 surveys, the prevalence of low resilience level (BRS score 1.00–2.99) was 36.4% (America/Europe) and 24.1% (Asia Pacific). Young age (18–29 years; adjusted odds ratio [aOR] = 0.31–0.58 in older age groups), female gender (aOR = 1.72, 95% C.I. = 1.34–2.20), poorer financial situation in the past 6 months (aOR = 2.32, 95% C.I. = 1.62–3.34), the presence of one (aOR = 1.56, 95% C.I. = 1.19–2.04) and more than two (aOR = 2.32, 95% C.I. = 1.59–3.39) medical conditions were associated with low resilience level. Individuals with low resilience were significantly more likely to consume substantially more alcohol than usual (aOR = 3.84, 95% C.I. = 1.62–9.08), take considerably more drugs (aOR = 12.1, 95% C.I. = 2.72–54.3), buy supplements believed to be good for treating COVID-19 (aOR = 3.34, 95% C.I. = 1.56–7.16), exercise less than before the pandemic (aOR = 1.76, 95% C.I. = 1.09–2.85), consume more unhealthy food than before the pandemic (aOR = 2.84, 95% C.I. = 1.72–4.67), self-isolate to stay away from others to avoid infection (aOR = 1.83, 95% C.I. = 1.09–3.08), have an excessive urge to disinfect hands for avoidance of disease (aOR = 3.08, 95% C.I. = 1.90–4.99) and transmission (aOR = 2.54, 95% C.I. = 1.57–4.10). Conclusions: We found an association between low resilience and maladaptive coping behaviours in the COVID-19 pandemic. The risk factors identified for low resilience in this study were also conditions known to be related to globalization-related economic and social inequalities. Our findings could inform design of population-based, resilience-enhancing intervention programmes. © 2023, The Author(s).
Filiaciones:
JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Department of Sports Science and Physical Education, The Chinese University of Hong Kong, Hong Kong
School of Public Health, Sun Yat-sen University, Guangzhou, China
The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China
Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China
Department of Global Health, School of Public Health, Peking University, Beijing, China
Center for Experimental Economics in Education, Shaanxi Normal University, Xi’an, China
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
North Ruijin Hospital, Shanghai Jiaotong University, Shanghai, China
Institute of Management, University of the Philippines Baguio, Baguio, Philippines
College of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand
Instituto de Investigaciones en Biomedicina iBioMed, Universidad San Francisco de Quito, Quito, Ecuador
Colegio de Ciencias de La Salud, Escuela de Medicina, Universidad San Francisco de Quito, Quito, Ecuador
Sistemas Médicos SIME, Universidad San Francisco de Quito, Quito, Ecuador
Institute of Legal Research, National Autonomous University of Mexico (UNAM), Mexico, Mexico
Department of Psychiatry, Faculty of Medicine, The University of British Columbia, Vancouver, Canada
i3S-Instituto de Investigação E Inovação Em Saúde, Universidade Do Porto, Porto, Portugal
Department of Population and Public Health Sciences, APRU Global Health Program, Keck School of Medicine, University of Southern California, Soto Street Building, MC 9239, Los Angeles, CA 90089-9239, United States
Chinese Univ Hong Kong, Fac Med, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China
Chinese Univ Hong Kong, Fac Med, Ctr Hlth Educ & Hlth Promot, Hong Kong, Peoples R China
Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Peoples R China
Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China
Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen, Peoples R China
Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China
Peking Univ, Sch Publ Hlth, Dept Global Hlth, Beijing, Peoples R China
Shaanxi Normal Univ, Ctr Expt Econ Educ, Xian, Peoples R China
Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing, Peoples R China
Shanghai Jiao Tong Univ, North Ruijin Hosp, Shanghai, Peoples R China
Univ Philippines Baguio, Inst Management, Baguio, Philippines
Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand
Univ San Francisco Quito, Inst Invest & Biomed iBioMed, Quito, Ecuador
Univ San Francisco Quito, Escuela Med, Colegio Ciencias Salud, Quito, Ecuador
Univ San Francisco Quito, Sistemas Med SIME, Quito, Ecuador
Natl Autonomous Univ Mexico UNAM, Inst Legal Res, Mexico City, Mexico
Univ British Columbia, Fac Med, Dept Psychiat, Vancouver, BC, Canada
Univ Porto, i3S Inst Invest & Inovacao Saude, Porto, Portugal
Univ Southern Calif, Keck Sch Med, Dept Populat & Publ Hlth Sci, APRU Global Hlth Program, Soto St Bldg, MC 9239, Los Angeles, CA 90089 USA
Green Published, gold, All Open Access; Gold
|